A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

ישראלמגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Solid Tumor

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Christiana Care Health System- Site Number : 8400011, Newark, Delaware, United States

    Contact: Study coordinator (Jamal Misleh) · Jamal.misleh@usoncology.com · 302-366-1200
    Contact: Principal Investigator (Jamal Misleh)
  • University of Iowa- Site Number : 8400014, Iowa City, Iowa, United States

    Contact: Study coordinator (Muhammad Furquan) · muhammad-furqan@uiowa.edu · 319-356-1527
    Contact: Principal Investigator (Muhammad Furquan)
  • University of Kansas Cancer Center Clinical Research Center (Fairway) Site Number : 8400008, Fairway, Kansas, United States

    Contact: Study coordinator (Lisa Bogart) · CTNurseNav@kumc.edu · 913-945-7552
    Contact: Principal Investigator (Joaquina Baranda)
  • Barbara Ann Karmanos Cancer Institute - Detroit- Site Number : 8400006, Detroit, Michigan, United States

    Contact: Study coordinator (Ammar Sukari) · sukaria@karmanos.org · 313-576-8751
    Contact: Principal Investigator (Ammar Sukari)
  • John Theurer Cancer Center Site Number : 8400001, Hackensack, New Jersey, United States

    Contact: Study coordinator (Suzanne Kosky) · suzanne.kosky@hmhn.org · 551-996-3986
    Contact: Principal Investigator (Martin Gutierrez)
  • NYU Langone Medical Center-New York- 550 1st Ave - BRANY - PPDS- Site Number : 8400013, New York, New York, United States

    Contact: Study coordinator (Paul Oberstein) · paul.oberstein@nyulangone.org · 212-731-6120
    Contact: Principal Investigator (Paul Oberstein)
  • Rhode Island Hospital Site Number : 8400004, Providence, Rhode Island, United States

    Contact: Study coordinator (Kaitlyn Krar) · CKrar@Lifespan.org · 401-444-4818
    Contact: Principal Investigator (Khaldoun Almhanna)
  • University of Texas MD Anderson Cancer Center Site Number : 8400005, Houston, Texas, United States

    Contact: Study coordinator (Aung Naing) · anaing@mdanderson.org · 713-794-5555
    Contact: Principal Investigator (Aung Naing)
  • Fred Hutchinson Cancer Center - 825 Eastlake Ave E- Site Number : 8400010, Seattle, Washington, United States

    Contact: Study coordinator (Elena Chiorean) · gchiorea@seattlecca.org · 206-606-6248
    Contact: Principal Investigator (Elena Chiorean)
  • Servicios Médicos URUMED SpA_Investigational Site Number : 1520002, Rancagua, General Bernardo O'Higgins, Chile

    Contact: Study coordinator (Plinio Fernandez) · pliniofernandez@urumed.cl · 56 9 8902 2206
    Contact: Principal Investigator (Plinio Fernandez)
  • BIOCINETIC Ltda_Investigational Site Number : 1520008, Santiago, Reg Metropolitana de Santiago, Chile

    Contact: Study coordinator (Nicolas Obando Martínez) · nicolas.obando@cecim.cl · 569 90790781
    Contact: Principal Investigator (Nicolas Obando Martínez)
  • Fundacion Arturo Lopez Perez (FALP) - Providencia - Jose Manuel Infante 805_Investigational Site Number : 1520007, Providencia, Chile

    Contact: Study coordinator (Christian Caglevic Medina) · christian.caglevic@falp.org · (562) 242-0509
    Contact: Principal Investigator (Christian Caglevic Medina)
  • Centro de Investigacion Clinica Bradford Hill_Investigational Site Number : 1520004, Recoleta, Chile

    Contact: Study coordinator (Carlos Ignacio Rojas Garcia) · cirojas@bh.cl · 56 9 9874 4662
    Contact: Principal Investigator (Carlos Ignacio Rojas Garcia)
  • Hadassah Medical Center - PPDS_Investigational Site Number : 3760005, Jerusalem, Jerusalem, Israel

    Contact: Study coordinator (Jonathan Cohen) · cohenjon@hadassah.org.il · 972505172537
    Contact: Principal Investigator (Jonathan Cohen)
  • Shamir Medical Center_Investigational Site Number : 3760004, Be’er Ya‘aqov, Israel

    Contact: Study coordinator (Carmell Fink) · carmelf@shamir.gov.il · 972584882432
    Contact: Principal Investigator (Carmell Fink)
  • Sheba Medical Center - PPDS_Investigational Site Number : 3760003, Ramat Gan, Israel

    Contact: Study coordinator (Tamar Beller) · Tamar.Beller@sheba.health.gov.il · 972545964434
    Contact: Principal Investigator (Tamar Beller)
  • Tel Aviv Sourasky Medical Center Ichilov - PPDS_Investigational Site Number : 3760001, Tel Aviv, Israel

    Contact: Study coordinator (Ravit Geva) · ravitg@tlvmc.gov.il · 97236973494
    Contact: Principal Investigator (Ravit Geva)
  • Investigational Site Number : 3920001, Kashiwa-Shi, Japan

  • Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis_Investigational Site Number : 5280001, Amsterdam, North Holland, Netherlands

    Contact: Study coordinator (Marloes van Dongen) · mg.v.dongen@nki.nl · 31205129111
    Contact: Principal Investigator (Marloes van Dongen)
  • Erasmus MC_Investigational Site Number : 5280003, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Ferry Eskens) · f.eskens@erasmusmc.nl · 31107034897
    Contact: Principal Investigator (Ferry Eskens)
  • Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON_Investigational Site Number : 7240007, Barcelona, Spain

    Contact: Study coordinator (Elena Garralda) · egarralda@vhio.net · 34932746085
    Contact: Principal Investigator (Elena Garralda)
  • START MADRID_Hospital Universitario HM Sanchinarro - CIOCC_Investigational Site Number : 7240005, Madrid, Spain

    Contact: Study coordinator (Emiliano Calvo) · emiliano.calvo@startmadrid.com · 34917567825
    Contact: Principal Investigator (Emiliano Calvo)
מובילי המחקר
  • Clinical Sciences & Operations

    Study Director

    Sanofi